ArticleScientific reports2025
Fecal microbiomes from screening sampling tubes are stable despite varying sampling and storage conditions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07416760 (Analysis of the Composition of the Intestinal Microbiota and Its Evolution in Patients Post-intestinal Anastomosis), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Analysis of the Composition of the Intestinal Microbiota and Its Evolution in Patients Post-intestinal Anastomosis
Who cites it
2 citing papers in PubMed.
- Current Assessment of Existing Biospecimen Use in Population-Based Cancer Research.Biopreservation and biobanking · 2026Article
- Host-microbiome interactions in leukemia: mechanisms, treatment response, and clinical implications.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Residual material from fecal immunochemical test (FIT) tubes, commonly used in colorectal cancer screening programs, offers a valuable resource for large-scale gut microbiome studies. With recent advances in sequencing technologies, sequencing the full-length bacterial 16S ribosomal gene is now feasible. In this study, we evaluated the impact of pre-analytical handling conditions on microbiome profiling using FIT samples. Stool samples from eight healthy adults were subjected to various short-term (+ 20 °C) and long-term (-18 °C or -80 °C) storage conditions prior to DNA extraction. We also investigated the effects of sampling variation and the presence of buffer medium. Full-length 16S rRNA gene amplicons were generated and sequenced using Oxford Nanopore Technology to characterize the microbiome composition. Despite variations in sampling and storage conditions, microbiome richness, Shannon diversity, and individual characteristics were preserved, demonstrating the robustness of microbiomes extracted from FIT tubes. However, some variations were noted, such as increased amounts of collagenase-producing bacteria from 0.2 to 0.6% to 1.7-2.6% in samples stored at +20 °C for 4-10 days. Despite unsupervised and varying sampling and storage conditions, the fecal 16S rRNA microbiomes remained representative and robust. These findings support the usability of FIT samples for large-scale population microbiome research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.